Effect of Remimazolam on Motor Evoked Potential

• Status: Not yet recruiting
• Trial end date: 2023-02-28
• Target enrollment: 0
• Participant gender: All

Summary

This study was planned to investigate the degree of effect of remimazolam on MEP compared to propofol when monitoring the motion-inducing potential (MEP).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Korea University Guro Hospital
• Treatments: Propofol

Criteria

Inclusion Criteria:

• Aged 20-70

• Scheduled for elective spine surgery requiring monitoring of evoked potential

• ASA physical status 1-3

Exclusion Criteria:

• BMI ≥ 40

• Uncontrolled DM (HbA1c ≥ 9%)

• Contraindications to the study drug: known allergy or hypersensitivity

• Use of rate responsive cardiac pacemaker with bioelectrical impedence

• Diagnosed neuromuscular disorder

• Pre-existing motor weakness